Chest Pain Symptoms Differences Between Diabetic Patients and Non (chestpaindm)

December 4, 2024 updated by: Antonios Samir Ishak Ibrahim, Assiut University

Chest Pain Symptoms Differences Between Diabetes Mellitus and Non-diabetes Mellitus Patients with Acute Coronary Syndrome

Cardiovascular disease is the most severe cause of death among all non-infectious diseases and accountable for 17.5 million deaths in the world. Heart mortality in patients with DM is frequently associated with prevalence silent ischemia, which is triggered by autonomic neuropathy, thereby decreasing the chest pain felt by them

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Antonios S Ishak, Resident
  • Phone Number: 01226366806

Study Locations

  • Egypt
      • Assiut, Egypt, 2063045
        • Recruiting
        • Assiut University
        • Contact:
          • Antonios S Ishak, Resident

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All cases admitted to ED who meet the eligibility criteria will be recruited in this study after obtaining an informed consent chest pain of DM and non-DM patients with the acute coronary syndrome

Description

Inclusion Criteria:

i) Patients diagnosed with STEMI and NSTEMI ii) Both genders iii) above the age of 30 years iv) Patients with acute myocardial infarction with or without chest pain (angina) for 24 hours v) patients who are hemodynamically stable vi) patients without acute decompensated heart failure (ADHF) vii) patients without malignant arrhythmias viii) patients without in Acute Lung Oedem (ALO) condition ix) patients not using ventilator x) patient willing to and become respondents.

Exclusion Criteria:

i) Patients with several complications, thereby making it impossible to interview them ii) patients who have never undergone CABG surgery iii) patients who refuse to be respondents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
non diabetic
Device: ECG
Ecg detection for nstemi and stemi in diabetic and non diabetic paturnts
Other Names:
  • Echocardiography
diabetic
Device: ECG
Ecg detection for nstemi and stemi in diabetic and non diabetic paturnts
Other Names:
  • Echocardiography

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mortality
Time Frame: One month
One month
Hospital admission
Time Frame: 1 day
1 day
Intensive Care Unit admission
Time Frame: One week
One week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Investigators

  • Study Director: Essam El-dien M Abdullah, MD, Assiut University
  • Study Director: Zeinab Abd-Elatiff, MD, Ismailia Universiry
  • Study Director: Khalid Abdelbaky, MD, Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 10, 2025

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

July 26, 2024

First Submitted That Met QC Criteria

December 4, 2024

First Posted (Actual)

December 5, 2024

Study Record Updates

Last Update Posted (Estimated)

December 6, 2024

Last Update Submitted That Met QC Criteria

December 4, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • chestpain

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe